← Leaderboards
Bradley K McConnell
University Of Maryland Baltimore
$3,958,411
Attributed
$3,958,411
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $641K · FY2007–25$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,958,411 · 5
By mechanism
R01$2,279,585 · 1
R15$1,361,666 · 3
R25$317,160 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Maureen E O'Donnell$78,496
- Lin Zou$4,006,863
- Paul A Welling$21,115,168
Others in their field
Top investigators on “Heart”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S Hochman · New York University School Of Medicine$118,439,174
- Deborah Nickerson · University Of Washington$86,844,068
- Rebecca Montalvan · Westat, Inc.$86,600,000
Research focus
HeartCardiacA Kinase Anchoring ProteinChronicGravinAdrenergic ReceptorIn VivoMediatingProtein FunctionSignal TransductionHeart FailureReceptorAkap12 GeneHeart DiseasesPhosphorylationResponseCyclic Amp-Dependent Protein KinasesComplexBinding (Molecular Function)BaseCyclic AmpBlood PumpGene ExpressionGene Transfer
Grant awards (12)
University of Houston Cardiovascular Undergraduate Research Experience (UH-CURE)$158,580
R25 · FY2025 · HL · contact PI
University of Houston Cardiovascular Undergraduate Research Experience (UH-CURE)$158,580
R25 · FY2024 · HL · contact PI
Gravin Signalosome Protein Coordinates Cardiac Function via Adrenergic Receptor Signaling$459,000
R15 · FY2019 · HL · contact PI
Scaffolding Protein Interaction Network Regulates Cardiac Cell Signaling$451,500
R15 · FY2015 · HL · contact PI
Molecular Mechanism of Dilated Cardiomyopathy$451,166
R15 · FY2013 · HL · contact PI
Targeted Disruption of Beta-Adrenergic Signaling to Increase Cardiac Contractilit$420,778
R01 · FY2011 · HL · contact PI
Targeted Disruption of Beta-Adrenergic Signaling to Increase Cardiac Contractilit$420,741
R01 · FY2010 · HL · contact PI
Targeted Disruption of Beta-Adrenergic Signaling to Increase Cardiac Contractilit$15,047
R01 · FY2010 · HL · contact PI
Targeted Disruption of Beta-Adrenergic Signaling to Increase Cardiac Contractilit$380,159
R01 · FY2009 · HL · contact PI
Targeted Disruption of Beta-Adrenergic Signaling to Increase Cardiac Contractilit$260,876
R01 · FY2009 · HL · contact PI
Targeted Disruption of Beta-Adrenergic Signaling to Increase Cardiac Contractilit$382,761
R01 · FY2008 · HL · contact PI
Targeted Disruption of Beta-Adrenergic Signaling to Increase Cardiac Contractilit$399,223
R01 · FY2007 · HL · contact PI